breaking news, page-27

Market will include several consolidating measures though in regards to a very strong rally.

1,
Thermalife is a relaunch, not an entirely new product.
It had in the past never been in the money.
What weakens this cautious argument is the science behind the new product which works fantastically and effectiveness and compounds are scientifically fully understood by its producing company.
Hence the rightful assessment that we are dealing in fact with a new product under the same name.

2,
When share rallied a year ago it did so with 200mil shares less available in the register. One would already have to discount about 20% off the peak of the rally due to dilution if direct comparison to that rally is the point.


3,
Sophs have been mercilessly riding these pumps and dumps in the past, one only needs to remember the full 20 minutes last time anybody had time to make money before it was all over.
Interestingly, this time round no sophs are really selling into our latest buying momentum which is surprising.
Could it be that they are aware that even their free options will be in the money this time and wait to offload until that moment arrives. It is only a few months away and would be the most lucrative move.
PNO will at some point in the near future experience the exit of the sophs, they are here, most likely, only here for an investment and will not be overly involved in the overall story, or they would have been around longer in the past after their share allocations.

4,
Many shares run hard on speculation and cautiously on facts.
The outlook for revenue though will give this rally sustainability and that will protect shareprice from being battered too hard back after peaking.



Overall, we look at a mixed bag for the outlook with a healthy expectation of a reasonable rally though.
If the prelude to the rally is any indication, the price is very sustained and refers to more support in the uptrend than previously seen in the last years.